Inventor · disambiguated record
Uday Saxena
Also filed as: SAXENA UDAY
30 granted patents·14 pending applications·378 citations·filing 1986–2025
97Inventor score
Files withREDDY US THERAPEUTICS INC19ATHEROGENICS INC4SAXENA UDAY3LAY SCIENCES INC2TIMMER RICHARD T2
Top patents by PatentIndex Score
44 records- 0195US7169785B2Methods and compositions of novel triazine compoundsREDDY US THERAPEUTICS INC·Filed 2003·Granted Jan 30, 2007·58 cites·29 claims
- 0294US7112587B2Methods and compositions of novel triazine compoundsREDDY US THERAPEUTICS INC·Filed 2003·Granted Sep 26, 2006·50 cites·6 claims
- 0391US7163943B2Methods and compositions of novel triazine compoundsREDDY US THERAPEUTICS INC·Filed 2003·Granted Jan 16, 2007·34 cites·6 claims
- 0488US6887712B1Methods and compositions to lower plasma cholesterol levelsATHEROGENICS INC·Filed 1999·Granted May 3, 2005·53 cites·9 claims
- 0587US11701423B2Hyperimmunized egg product for treatment or prevention of coronavirus infectionLAY SCIENCES INC·Filed 2022·Granted Jul 18, 2023·2 cites·7 claims
- 0686US7335656B2Medical devices employing triazine compounds and compositions thereofREDDY US THERAPEUTICS INC·Filed 2006·Granted Feb 26, 2008·4 cites·22 claims
- 0786US6881860B2Compounds and methods to increase plasma HDL cholesterol levels and improve HDL functionalityATHEROGENICS INC·Filed 2001·Granted Apr 19, 2005·27 cites·33 claims
- 0885US7332488B2Methods and compositions of novel triazine compoundsREDDY US THERAPEUTICS INC·Filed 2006·Granted Feb 19, 2008·4 cites·20 claims
- 0984US7132423B2Methods and compositions of novel triazine compoundsREDDY US THERAPEUTICS INC·Filed 2003·Granted Nov 7, 2006·11 cites·6 claims
- 1083US7332490B2Methods and compositions of novel triazine compoundsREDDY US THERAPEUTICS INC·Filed 2006·Granted Feb 19, 2008·4 cites·24 claims
- 1182US7265114B2Methods and compositions of novel triazine compoundsREDDY US THERAPEUTICS INC·Filed 2005·Granted Sep 4, 2007·5 cites·39 claims
- 1282US4775483AMethod to reduce plasma cholesterolCANADIAN PATENTS DEV·Filed 1986·Granted Oct 4, 1988·58 cites·10 claims
- 1381US7169784B2Medical devices employing triazine compounds and compositions thereofREDDY US THERAPEUTICS INC·Filed 2004·Granted Jan 30, 2007·11 cites·5 claims
- 1480US7173032B2Methods and compositions of novel triazine compoundsREDDY US THERAPEUTICS INC·Filed 2003·Granted Feb 6, 2007·14 cites·70 claims
- 1578US7268134B2Medical devices employing triazine compounds and compositions thereofREDDY US THERAPEUTICS INC·Filed 2004·Granted Sep 11, 2007·7 cites·5 claims
- 1676US8008328B2Methods for the treatment of diabetes-associated dyslipdemiaREDDY US THERAPEUTICS INC·Filed 2007·Granted Aug 30, 2011·2 cites·11 claims
- 1775US8846721B2Compositions for reducing aβ 42 production and their use in treating alzheimer's disease (AD)AKELLA VENKATESWARLU·Filed 2011·Granted Sep 30, 2014·4 cites·13 claims
- 1871US12324441B2Hyperimmunized egg product for treatment or prevention of coronavirus infectionLAY SCIENCES INC·Filed 2023·Granted Jun 10, 2025·0 cites·14 claims
- 1971US7332489B2Methods and compositions of novel triazine compoundsREDDY US THERAPEUTICS INC·Filed 2003·Granted Feb 19, 2008·4 cites·26 claims
- 2070US7238692B2Medical devices employing triazine compounds and compositions thereofREDDY US THERAPEUTICS INC·Filed 2004·Granted Jul 3, 2007·4 cites·18 claims
- 2168US6747061B2N-substituted dithiocarbamates for the treatment of biological disordersATHEROGENICS INC·Filed 2001·Granted Jun 8, 2004·4 cites·59 claims
- 2265US2007004729A1Methods and compositions of novel triazine compoundsTIMMER RICHARD T·Filed 2006·Application pending·0 cites
- 2363US7335770B2Triazine compounds and their analogs, compositions, and methodsREDDY U5 THERAPEUTICS INC·Filed 2004·Granted Feb 26, 2008·4 cites·1 claims
- 2461US2008275049A1Methods and Compositions for Upregulation of GATA ActivityREDDY US THERAPEUTICS INC·Filed 2008·Application pending·0 cites
- 2560US6900041B2Methods and compositions for the treatment of inflammatory diseasesREDDY US THERAPEUTICS INC·Filed 2001·Granted May 31, 2005·3 cites·27 claims
- 2660US2005065121A1Methods to increase plasma HDL cholesterol levels and improve HDL functionality with probucol monoestersFiled 2004·Application pending·0 cites
- 2758US7273712B2Methods and compositions for detecting compounds that modulate inflammatory responsesREDDY US THERAPEUTICS INC·Filed 2001·Granted Sep 25, 2007·1 cites·12 claims
- 2857US12502428B1Immunotherapeutic composition for prevention of obesity, nonalcoholic fatty liver disease and hypertriglyceridemia, and methods of use and preparation thereofUTOPIA THERAPEUTICS PVT LTD·Filed 2025·Granted Dec 23, 2025·0 cites·10 claims
- 2957US6656699B2Methods and compositions for glycosidase assaysREDDY US THERAPEUTICS INC·Filed 2001·Granted Dec 2, 2003·1 cites·20 claims
- 3056US7183317B2Compounds and methods to increase plasma HDL cholesterol levels and improve HDL functionalityATHEROGENICS INC·Filed 2004·Granted Feb 27, 2007·1 cites·9 claims
- 3155US2007043051A1Methods and compositions of novel triazine compoundsTIMMER RICHARD T·Filed 2006·Application pending·0 cites
- 3255US2025262226A1Combinations of vitamin d3, niacinamide and lipoic acid for use in the maintenance of healthy blood glucose levelsCHANDRASEKHAR SATISHCHANDRAN·Filed 2023·Application pending·0 cites
- 3353US2005118564A1Methods and compositions for identification and therapeutic use of genes involved in vascular and proliferative diseasesFiled 2003·Application pending·0 cites
- 3450US2005196819A1Methods and compositions to lower plasma cholesterol levelsATHEROGENICS PHARMACEUTICALS I·Filed 2005·Application pending·0 cites
- 3547US9464053B2Compositions for reducing Aβ 42 production and their use in treating alzheimer's disease (AD)KAREUS THERAPEUTICS SA·Filed 2014·Granted Oct 11, 2016·0 cites·8 claims
- 3647US2014322320A1Novel compositions for emesis control in cancer patients undergoing chemotherapy and methods thereofSAXENA UDAY·Filed 2014·Application pending·0 cites
- 3747US2008119571A1Compositions and methods to enhance reverse cholesterol transportREDDY US THERAPEUTICS INC·Filed 2007·Application pending·0 cites
- 3846US2014243282A1Methods and compositions for designing novel conjugate therapeuticsKALLAM SATISH REDDY·Filed 2011·Application pending·0 cites
- 3945US8541435B2Niacin compositions for reduction of amyloid beta peptide 42 (abeta 42) production and for treatment of Alzheimer's disease (AD)SAXENA UDAY·Filed 2009·Granted Sep 24, 2013·0 cites·6 claims
- 4045US2010297673A1Methods and compositions for upregulation of peroxiredoxin activityREDDY US THERAPEUTICS·Filed 2007·Application pending·0 cites
- 4145US2013338199A1Novel Niacin Compositions for Reduction of Amyloid Beta Peptide 42 (AB42) Production and for Treatment of Alzheimer's DiseaseSAXENA UDAY·Filed 2013·Application pending·0 cites
- 4244US2003036103A1Methods and compositions for diagnosis and treatment of vascular conditionsFiled 2002·Application pending·0 cites
- 4343US6231847B1Method of treating vascular proliferative responsesBISGAIER CHARLES LARRY·Filed 1999·Granted May 15, 2001·8 cites·10 claims
- 4441US2003064967A1Methods to increase plasma HDL cholesterol levels and improve HDL functionality with probucol monoestersFiled 2002·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Uday Saxena files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →